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Abstract 
Hagman, R. 2005. New aspects of Canine Pyometra – Studies on Epidemiology and 
Pathogenesis. Doctor’s dissertation.  
ISSN 1401-6257, ISBN 91-576-6682-2. 
 
Pyometra is a common and lethal disease in bitches characterised by uterine bacterial 
infection leading to subsequent systemic illness. The objectives of the present thesis were to 
investigate the incidence of the disease in relation to breed and age, to assess 
bacteriological aspects of pyometra and to evaluate the involvement of endotoxin and 
prostaglandin F2α in the pathogenesis. 
Animal insurance data revealed age- and breed-dependent differences in the incidence of 
pyometra. On average 23-24% of all bitches studied experienced pyometra before 10 years 
of age. Data presented in this study indicate that certain breeds have a genetic pre-
disposition for pyometra.  
Bacteriological genotype examinations showed that pyometra is most likely caused by 
Escherichia coli clones originating from the normal flora of each dog, i.e. not by clones 
spreading between animals. The resistance among E. coli isolates from pyometra bitches 
against antimicrobials commonly used in canine practice was low and not likely to cause 
therapy failure. Data on antimicrobial resistance of E. coli from urinary tract infections 
were generally not suitable for selecting antimicrobial treatment of pyometra. 
Systemic endotoxemia was confirmed in bitches with pyometra. The plasma levels of 
endotoxin were correlated with concentrations of the prostaglandin F2α metabolite (PG-
metabolite). This indicates the usefulness of PG-metabolite in the diagnosis of endotoxemia 
in bitches. Bitches with pyometra also had increased blood concentrations of PG-metabolite 
compared with bitches with cystic endometrial hyperplasia (CEH). The present study 
revealed that in bitches with fluid in the uterus, the analysis of PG-metabolite in 
combination with percentage band neutrophils can distinguish between pyometra and CEH. 
The levels of PG-metabolite are predictive of the severity of pyometra since they were 
correlated to criteria of a systemic inflammatory response and also to the length of 
hospitalisation. 
In summary, this thesis provides data on breed- and age-related differences in the incidence 
of pyometra, which will be helpful in future studies of the disease and breeding 
programmes. In addition, clarification of key bacteriological and pathophysiological 
characteristics of the development of pyometra can improve diagnostic and therapeutic 
strategies and increase survival rates. 
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 Abbreviations 
ALAT        Alanine  aminotransferase 
A l b         A l b u m i n  
A/G      Albumin  -  globulin  quote 
ALP         Alkaline  phosphatase 
ASAT        Aspartate  aminotransferase 
B A         B i l e   a c i d s  
BUN       Blood  urea  nitrogen 
Urea       Blood  urea  nitrogen 
BN        Band  pneutrophils 
CEH       Cystic  endometrial  hyperplasia 
CHEF     Contour-clamped  homogenous  electric  field 
C K         C r e a t i n e   k i n a s e  
CNF       Cytotoxic  necrotising  factor 
Crea      Creatine 
EPC      Erythrocyte  particle  concentration 
EVF      Erythrocyte  volume  fraction 
ET        Endotoxin 
G l u         G l u c o s e  
Hb        Hemoglobin 
Hct        Hematocrit 
H R         H e a r t   r a t e  
LAL       Limulus  amoebocyte  lysate 
MIC      Minimum  inhibitory  concentration 
Mono       Monocytes 
PBN       Percentage  band  neutrophils 
PCV       Packed  red  blood  cell  volume 
PFGE       Pulsed-field  gel  electrophoresis 
PG        Prostaglandin 
PG-metabolite   Prostaglandin 15-keto-13,14-dihydro-PGF2α metabolite  
P r o t         P r o t e i n  
RIA      Radioimmunoassay 
R R         R e s p i r a t o r y   r a t e  
SIRS       Systemic  inflammatory  response  syndrome 
SLU      Swedish  University  of  Agricultural Sciences, Uppsala, Sweden 
SVA       National  Veterinary  Institute,  Uppsala,  Sweden 
Temp       Body  temperature 
UTI        Urinary  tract  infection 
WBC       White  blood  cell  count   7 
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Introduction 
Pyometra in bitches - a background 
Pyometra is a common metoestral disease of intact adult bitches (Dow, 1958). It is 
characterised by uterine bacterial infection with pus accumulating in the uterus 
and systemic illness (Børresen, 1975). The disease is associated with a variety of 
clinical symptoms and is life-threatening in severe cases (Sevelius, Tidholm & 
Thorén-Tolling, 1990; Okano, Tagawa & Takase, 1998). Despite being an 
important reproductive disease and the focus of research in canine veterinary 
medicine since the 1920´s (Möller Sörensen, 1929), central aspects of the complex 
aetiology and pathogenesis of the disease are obscure or unknown. 
 
Several terms, such as chronic endometritis, chronic purulent metritis or cystic 
endometrial hyperplasia - pyometra complex, have been used in the literature to 
describe the condition (Teunissen, 1952; Dow, 1957; Sandholm, Vasenius & 
Kivistö, 1975). The definition of canine pyometra as a chronic purulent 
endometritis post estrum, with or without polysystemic effects will be used 
throughout this thesis (adapted after Hardy & Osborne, 1974).  
 
In Scandinavian countries, a large dog population is at risk of developing uterine 
disorders such as pyometra since elective neutering of healthy bitches is seldom 
performed. In Sweden neutering (spaying) is mainly performed as a result of 
medical problems and consequently only 7% of the bitches are neutered (Egenvall 
et al., 1999). The situation is different in many other countries, e.g. in the USA 
(Manning & Rowan 1992) and Australia (Blackshaw & Day, 1994) where elective 
spaying is common practice and performed in 85% and more than 50% of all 
bitches, respectively.  
 
The possible predisposition for pyometra in different breeds has been evaluated 
in a few studies, but was not assessed in relation to the base dog population 
(Krook, Larsson & Rooney, 1960; Ewald, 1961; Niskanen & Thrusfield, 1998). 
Increased risk of the development of pyometra has been associated with e.g. 
hormone therapy and nulliparity (Niskanen & Thrusfield, 1998), whereas for 
contrast overt pseudopregnancy might be a protective factor (Fidler et al., 1966).  
 
 
Pathogenesis 
Pyometra is developed as a result of a complex of aetiological factors. These 
include the hormonal influence on the uterine environment, virulence of the 
infecting bacteria, the general ability of the bitch to combat the infection and the 
individual sensitivity to bacterial and inflammatory products (Fig. 1). 
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Fig. 1. Conceptual and generalised model of factors involved in the pathogenesis of canine 
pyometra. 
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The CEH-pyometra complex 
It is generally believed that cystic endometrial hyperplasia (CEH) is caused by 
repeated exposure of the endometrium to progesterone during the relatively long 
luteal phase of the oestrus cycle in bitches (Hardy & Osborne, 1974). Presence of 
CEH predisposes the uterus for secondary bacterial infection leading to pyometra 
(Dow, 1959a, 1959b). In CEH the endometrial walls are thickened with a 
pathological proliferation and growth of the endometrial glands (Dow, 1958). 
CEH can be accompanied by sterile fluid in the uterine lumen which is defined as 
mucometra or hydrometra depending on the degree of hydration of the mucin 
(Dow, 1958). The act of repeated progestational stimulation in the pathogenesis is 
supported by the fact that CEH and pyometra mainly affect middle-aged and older 
bitches (Benesch & Pommer, 1930; Dow, 1958). The concept of the "cystic 
endometrial hyperplasia - pyometra complex" where CEH initiates a gradually 
developing pathological process with pyometra as the most severe end-stage, was 
introduced by Dow (1957). Dow (1957, 1958, 1959a, 1959b) divided bitches with 
the disease bitches into four groups based on histopathological examinations of the 
uteri: (І) uncomplicated CEH, (ІІ) CEH with plasmacell infiltration, (ІІІ) CEH 
with acute endometritis and (ІV) chronic endometritis/pyometra. However, a 
recent study suggested that CEH and pyometra should be regarded as two separate 
entities based on their clinical manifestations and morphohistological differences 
(De Bosschere et al., 2001). In that study it was also determined that CEH and 
pyometra can develop independently of each other (De Bosschere et al., 2001).  
 
The role of hormones 
Since early attempts to produce pyometra by experimental bacterial infection 
failed, hormonal dysfunctions were thought to be the most important aetiological 
factor of pyometra (Benesch & Pommer, 1930; Lesboyries and Berthelon, 1935). 
Given that pyometra mainly appears in metoestrus and can be produced by 
experimental progesterone injections, increased or prolonged secretions of 
progesterone were believed to initiate the disease (Teunissen, 1952; Dow, 1958, 
1959a). The progesterone-sensitised uterus is suitable not only for pregnancy but 
also for bacterial infection since progesterone stimulates endometrial gland growth 
and secretion, as well as cervical closure and suppression of myometrial 
contractions (Cox, 1970). In addition, progesterone has been shown to decrease 
the uterine resistance to bacterial infection in other animal species (Rowson, 
Lamming & Fry, 1953; Hawk, Turner & Sykes, 1960; Ganjam et al., 1982). 
Peripheral blood levels of oestrogen and progesterone in bitches with pyometra 
are, however, not abnormally elevated in most studies (Christie, Bell & Parkes, 
1972; Austad, Blom & Børresen, 1979; Hadley, 1975). Contrastingly, elevated 
blood levels of estradiol-17β (Ververidis et al., 2004) and progesterone 
(Vandeplassche, Coryn & De Schepper, 1991) have also been measured in 
pyometra bitches compared with healthy ones. Oestrogen alone has not 
experimentally been able to induce pyometra, but it enhances the effect of 
subsequently administered progesterone (Dow, 1959a; Teunissen, 1952). This 
could explain why oestrogen therapy has been associated with increased risk of 
pyometra (Bowen et al., 1985; Dhaliwal, England & Noakes, 1999; Niskanen & 
Thrusfield, 1998). The synergistic effect of oestrogen and progesterone in the   12
pathogenesis of uterine disorders is further indicated by the more frequent findings 
of simultaneous ovarian follicles and corpora lutea in bitches with diseased uteri 
compared with healthy ones (Ström Holst et al., 2001). Although physiologically 
present in lower concentrations than in most experimental studies, the functions of 
the ovary-derived hormones are clearly important in the pathogenesis since 
bilateral ovarioectomy prevents the development of the disease (Lesboyries & 
Berthelon, 1935).  
 
Recent investigations have explored the possibility of pyometra being induced 
by an exaggerated uterine response to normal hormone levels (Dhaliwal, England 
& Noakes, 1997; Ververidis et al., 2004). The expression of steroid receptors has 
been shown to be different in uteri with CEH and pyometra compared with healthy 
bitches (De Cock et al., 1997; Sauerwein et al., 1998; De Bosschere et al., 2002; 
Ververidis et al., 2004). Although yet uncertain, hormone receptors may thus play 
a role in the pathogenesis of the disease. 
 
The role of bacteria 
Bacteria, predominantly Escherichia coli, are isolated in most (62-90%) pyometra 
cases (Grindlay, Renton & Ramsay, 1973; Sandholm, Vasenius & Kivistö, 1975; 
Fransson et al., 1997; Bigliardi et al., 2004). This predominance might simply be 
because E. coli are natural inhabitants of the vaginal flora and gain entrance to the 
uterus during proestrus and oestrus (Watts, Wright & Whithear, 1996). The ability 
of E. coli to adhere to specific receptors in progesterone-stimulated endometrium 
is probably also important for the establishment of infection (Sandholm, Vasenius 
& Kivistö, 1975). The origin of the E. coli strains found in pyometra is most likely 
the normal flora of the bitch or the urinary tract since a simultaneous subclinical 
urinary tract infection commonly is present (Sandholm, Vasenius and Kivistö, 
1975; Wadås et al., 1996). Normally the healthy uterus is capable of eliminating 
entering bacteria without further development of uterine pathologies (Watts, 
Wright & Whithear, 1996). This was experimentally shown by Nomura and co-
workers (1988), who inoculated a known pathogenic pyometra-derived E. coli 
strain into the vagina of 216 healthy bitches. Persistent uterine disease was not 
induced in any of the bitches despite apparent bacterial invasion into the uterine 
cavities.  
 
Certain serotypes of E. coli are isolated more frequently in pyometra (Grindlay, 
Renton & Ramsay, 1973; Choi & Kawata, 1975; Sandholm, Vasenius & Kivistö, 
1975; Dhaliwal, Wray & Noakes, 1998), which most likely depends on virulence 
factors associated with these serotypes increasing their ability to establish and 
maintain an infection in the uterus (Chen et al., 2003). One probable virulence trait 
is production of cytotoxic necrotising factor (CNF), which has been shown to 
increase endothelial damage and provoke a greater inflammatory reaction in 
pyometra (Dhaliwal, Wray & Noakes, 1998). The more virulent E. coli strains 
might be spread between dogs, either directly causing disease or be harboured in 
the normal bacterial flora for longer or shorter times until favourable conditions 
develop. This has been shown in urinary tract infections in man (Kühn, Tullus & 
Möllby, 1986).    13 
 
 
 
Clinical manifestations 
The clinical manifestations of canine pyometra are well described in the literature 
(Hardy & Osborne, 1974; Børresen, 1975). A bitch suffering from pyometra is 
classically presented in metoestrus, with a history of a variety of symptoms 
associated with both genital and extragenital lesions. A purulent vaginal discharge 
is often present provided the cervix is open. Common symptoms associated with 
the polysystemic disease are dehydration, polydipsia, polyuria, lethargy, 
abdominal pain, anorexia, vomiting or diarrhoea, fever or hypothermia, abnormal 
colour of the mucous membranes and elevated heart- and respiratory rates 
(Børresen, 1979). The clinical course of the disease, and consequently the 
symptoms, vary from prolonged development of chronic uterine inflammation to, 
more rarely, sudden death in endotoxic shock (Hardy & Osborne, 1974).  
 
Pyometra induces disturbed organ functions which are noted in the 
hematological and blood biochemical examinations. Classically there is 
leucocytosis, with neutrophilia and left shift in the differential white blood cell 
count (Børresen, 1980). Occasionally leucopenia is present (Børresen, 1980). A 
normocytic, normochromic anemia is thought to reflect the chronicity of the 
disease, decreased erythropoesis due to toxic effects on the bone marrow, lack of 
available iron and loss of erythrocytes to the uterus (De Schepper, Van Der Stock 
& Capiau, 1987). Dehydration often complicates the evaluation of anemia 
(Børresen, 1980). Hypoalbuminemia and hyperproteinemia are frequent findings, 
reflecting loss of albumin via the kidneys and increased production of 
gammaglobulines (Åsheim, 1965; Børresen, 1980; Børresen & Skrede, 1980). 
Decreased levels of the enzyme alanine aminotransferase (ALAT), due to 
inhibition of liver enzyme synthesis or hepatic membrane damage, and increased 
levels of aspartate aminotransferase (ASAT) are also associated with pyometra 
(De Schepper, Van Der Stock & Capiau, 1987). Evaluation of admitted bitches 
with pyometra often includes parameters assessing kidney function since renal 
disease and renal failure are not uncommon complications to pyometra (Capiau, 
De Schepper & Van Der Stock, 1987; Stone et al., 1988; Wheaton et al., 1987, 
Åsheim 1964, 1965). Elevated concentrations of alkaline phosphatase (ALP), 
bilirubin and cholesterol concentrations probably reflect intrahepatic cholestasis 
(Børresen, 1980; Børresen & Skrede, 1980; Sevelius, Tidholm & Thorén-Tolling, 
1990).  
 
Treatment 
The treatment of choice has traditionally been ovariohysterectomy (Hardy & 
Osborne, 1974), but in some cases the bitches can be too severely affected to 
survive (Wheaton et al., 1987). Supportive treatments such as intravenous fluids 
are often administered in conjunction with surgical treatment of pyometra 
(Johnson, 1995). In Sweden the policy regarding the administration of 
antimicrobials is restrictive. At the Veterinary Hospital in Uppsala antimicrobial   14
treatment is only administered to surgically treated pyometra bitches with 
moderately to severely deteriorated clinical status, peritonitis or surgical 
complications such as uterine rupture.  
 
Medical treatment of pyometra with compounds promoting expulsion of the 
uterine pus, in combination with antimicrobials, is an option in some cases 
depending on the status of uterus and the general condition of the bitch (Meyers-
Wallen, Goldschmidt & Flickinger, 1986; Trasch, Wehrend & Bostedt, 2003; 
Gobello et al., 2003). Intra-uterine drainage is also a possibility (Funkquist et al., 
1983). The fertility may thus be preserved, although decreased, but with high 
probability of recurrence of the disease (Nelson, Feldman & Stabenfelt, 1982; 
Meyers-Wallen, Goldschmidt & Flickinger, 1986; Gilbert, Nöthling, & Oettle, 
1989; Trasch, Wehrend & Bostedt, 2003; Gobello et al., 2003). 
 
The type of antimicrobial drug chosen for adjunctive pyometra treatment is 
mainly based on previous knowledge of antimicrobial susceptibility of E. coli. 
Studies performed in one country do not necessarily reflect the situation in another 
due to different traditions and regimes regarding the use of antimicrobials 
(Gandotra  et al., 1994; Yates, 1996; Pradhan et al., 1999; Lee et al., 2000; 
Wernicki, Krzyzanowski & Puchalski, 2002). In canines, most studies on E. coli 
are performed on isolates from urinary tract infections, another site from where E. 
coli also is the pathogen most commonly isolated (Low et al., 1988). Bacterial 
cultures from urinary tract infections are likely to be biased towards problematic 
cases, and it is uncertain if their resistance pattern is representative also of E. coli 
from pyometra (Bywater, 2000; Kerrn et al., 2002). 
 
 
Endotoxin  
Endotoxin (ET) is a lipopolysaccharide part of the outer cell wall of Gram-
negative bacteria, such as E. coli. The ET is released into the circulation during 
vigorous bacterial growth or cell disintegration and interacts with inflammatory 
and endothelial cells (Devoe & Gilchrist, 1973). When present in the blood, ET 
induces a wide range of biological effects and symptoms such as fever, lethargy 
and elevation of heart and respiratory rates (Van Miert & Frens, 1968). Among the 
ET activities are complement and coagulation cascade activation, platelet 
activation, generation of vasoactive kinins, cytokines, oxygen free radicals, the 
arachidonic acid-derived prostaglandins, tromboxane and platelet activating factor 
(Morrison and Ryan, 1987). Moderate production of these mediators are beneficial 
for stimulation of the immune system and microbial killing (Rietschel & Brade, 
1992). However, when released in large amounts ET can lead to fatal endotoxic 
shock with depression of the reticuloendothelial and circulatory systems (Goodwin 
& Schaer, 1989; Rietschel & Brade, 1992; Okano et al., 1993). Endotoxins in the 
circulation can also directly generate endothelial damage, disseminated 
intravascular coagulation and generalised organ failure (McAnulty, 1983; 
Rietschel & Brade, 1992).  
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In normal physiological conditions, minor quantities of ET originating from the 
intestinal bacteria constantly transmigrate the bowel mucosa and enter the portal 
circulation. The ET is then filtered by the Kuppfer cells and hepatocytes of the 
liver, preventing systemic endotoxemia (Nolan, 1981; Fox, Thomas & Broitman, 
1990). Normally the ET clearance from the circulation occurs within minutes and 
symptoms only develop when the hepatic capacity is exceeded (Wardle, 1975). 
 
Blood concentrations of ET have previously been related to outcome (survival 
or death) in cases of pyometra (Okano, Tagawa, & Takase, 1998). Bitches that 
died from the disease had significantly higher levels of ET (mean level 74.2 pg ml
-
1) compared with the survivors (mean level 9.5 pg ml
-1). This suggests that 
presurgical measurement of ET levels could be used as a marker for severity of the 
disease and for determination of the chance of survival. In humans endotoxemia 
usually precedes septicemia (Van Deventer et al., 1988). The early detection of 
endotoxemia, also in dogs, would allow for therapeutic intervention to prevent 
further development of septicemia. In another study, endotoxemia was detected 
prior to surgery in 15 bitches with pyometra, with tenfold higher mean levels than 
in the study by Okano and co-workers (1998), but all the bitches survived 
(Wessels & Wells, 1989). In contrast, endotoxemia was not consistently shown in 
two other studies of pyometra (Børresen & Naess, 1977; Fransson et al., 1997). 
All these results suggest that ET is involved in the pathogenesis of pyometra, but 
not always detectable due to variations in blood concentrations and in procedures 
of sampling and analysis.  
 
 
Prostaglandin F2α  
Prostaglandins are important in reproductive biology with many physiological and 
pharmacological roles and also as mediators in inflammatory events (Kindahl et 
al., 1976; Kindahl, 1980; Fredriksson, Kindahl & Edqvist, 1985). Prostaglandins 
are derived from arachidonic acid and are produced and released from neutrophils, 
macrophages, lymphocytes and platelets during inflammation (Kindahl, 1980). 
The systemic release of prostaglandin F2α (PGF2α) can be followed by 
measurement of its more stable main circulating metabolite 15-keto-13,14-
dihydro-PGF2α (PG-metabolite) (Granström & Kindahl, 1982). The uterine 
endometrium is also able to synthesise and release prostaglandins and mainly 
PGF2α (Heap & Poyser, 1975). Increased plasma levels of PG-metabolite have 
been measured in animals of several species, including the canine, with 
pathological inflammatory conditions of the uterus (Hughes et al., 1979; 
Vandeplassche, Coryn & De Schepper, 1991; Kindahl et al., 1992; Mateus et al., 
2003). A relation between plasma PG-metabolite levels and severity of uterine 
damage has been shown in cattle with post partum endometritis (Mateus et al., 
2003).  
 
In addition, bacterial ET is a potent inducer of prostaglandin release from 
macrophages and mononuclear cells (Morrison & Ryan, 1987). The PG-metabolite 
has been shown to be a reliable and sensitive marker of experimentally induced 
endotoxemia in cattle, goats, pigs and horses (Fredriksson, 1984; Fredriksson,   16
Kindahl & Edqvist, 1985, Holst, Edqvist & Kindahl, 1993; Daels et al., 1987). 
The PG-metabolite is, compared with ET, more stable, has a longer half-life and 
does not bind to sampling materials or proteins in plasma (Tobias, Soldau & 
Ulewitch, 1986). The role of prostaglandins in relation to endotoxin release in 
bitches with pyometra has not yet been determined. 
 
Pyometra is one of the canine bacterial infections potentially at risk of 
progressing into the systemic inflammatory response syndrome (SIRS) (Hardie, 
1995). Fulfilment of certain criteria, determined to predict SIRS, has previously 
been confirmed in over 50% of bitches suffering from the disease (Fransson, 
2003). SIRS is the response to an initial local inflammatory reaction which has 
shifted through the cascade release of the endogenous inflammatory mediators to 
an uncontrollable systemic reaction where mediators directly stimulate other 
mediators and continue without the presence of the initiating agent (McAnalty, 
1983; Purvis & Kirby, 1994). Various incidents such as severe trauma, infection 
or endotoxin can initiate a systemic inflammatory process which can be present 
with (septicemia) or without bacterial infection (Hardie, 1995). The presence of 
SIRS has been linked to lower survival rates and longer hospitalisation (Brady & 
Otto, 2001). Assessment of SIRS is therefore important to determine severity of 
the disease, optimise treatments and prevent fatal outcomes (Purvis & Kirby, 
1994).  
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Aims of this study 
The aims of the research presented in this thesis were to: 
 
•  Explore whether there are breed- and age-related differences in the incidence of 
pyometra in Sweden.  
 
• Determine whether pyometra is caused by closely related E. coli clones and 
whether morphologically different colony types isolated from one uterus are 
genetically similar.  
 
• Evaluate whether the infected uterus and the urinary tract in bitches with 
pyometra are infected with genetically related E. coli strains. 
  
• Determine the antimicrobial resistance of E. coli strains isolated from pyometra 
and urinary tract infections and to explore whether antimicrobial resistance is a 
cause of recurrence of the pyometra after medical treatment. 
 
• Evaluate whether data on antimicrobial resistance of E. coli from urinary tract 
infections can be used as a guide for drug selection in the treatment of pyometra. 
 
•  Explore whether endotoxemia is present in bitches with pyometra and study the 
possible use of hematological and blood biochemical parameters as markers for 
endotoxin release. 
 
•  Determine whether prostaglandin release is present in bitches with pyometra. 
 
• Evaluate whether the PG-metabolite concentration can be used as a marker for 
the severity of the disease and whether such data is useful in the differentiation of  
pyometra and cystic endometrial hyperplasia. 
  
 
   18
Materials and methods 
General descriptions of the materials and methods used in the studies presented in 
this thesis are described here. For further details, see papers I to V. 
 
 
Animals  
Bitches selected for the clinical studies were client-owned clinical cases at the 
Department of Small Animal Clinical Sciences, SLU, Uppsala, Sweden. The study 
periods were 1991-1994 and 1997 (II); 1991-1993 and 2002-2003 (III); 2001-
2002 (IV, V). The studies were approved prior to the onset of any investigations 
by the Uppsala County Regional Ethical Board. The presumptive diagnosis 
pyometra was confirmed by clinical examination combined with radiology, or 
ultrasound or both, and by macroscopic and histopathological examinations 
(Wadås et al., 1996; Fransson, 2003). In Study IV, bitches undergoing surgery for 
non-infectious reasons were used as a control group. Study V included clinically 
healthy, age-matched, intact bitches staying at the clinic as well as a group of 
bitches that had previously been enrolled in the study when ovariohysterectomised 
for pyometra.  
 
 
Study designs 
The purpose of Study I was to test the hypothesis that there are breed- and age-
related differences in the incidence of pyometra in Sweden. To assess the 
incidence of pyometra in bitches, data obtained from the insurance company Agria 
Försäkringar AB (P.O. Box 70306, SE-10723 Stockholm, Sweden) were 
evaluated. In Sweden it is common practice to insure dogs and over 30% of all 
Swedish dogs are insured by this company (Egenvall et al., 1999). The Agria data 
base included records on over 200,000 dogs for the years 1995 and 1996. There 
are two types of insurances that can be purchased separately or in combination: (1) 
veterinary care insurance, for which there is no age limit and (2) life-insurance, 
which is only valid up to ten years of age. Bitches up to ten years of age enrolled 
in both types of insurance in 1995 and 1996, respectively, were included in the 
study. The risks of pyometra were evaluated in thirty breeds represented by at least 
800 bitches insured in both 1995 and 1996. 
 
Study II was designed to evaluate the hypothesis that E. coli isolates from the 
uteri of bitches with pyometra are genetically similar. This would indicate the 
presence of particularly virulent bacterial clones and possibly also spread of these 
clones between animals. Eighty-four E. coli isolates from the uterus of 70 
pyometra bitches were examined with a genotyping method. The genotypes of 96 
different E. coli isolates within the uterus of ten other pyometra bitches were also 
studied. When morphologically different colony types could be isolated from the 
same bitch, all types were examined. In six bitches with pyometra and   19 
simultaneous urinary tract infection, the evaluated E. coli strains were tested to 
determine whether they were genetically related, identical or different by means of 
the chosen method. The method with restriction enzyme analysis and pused-field 
gel elecrophoresis (PFGE) is highly discriminatory and suitable for this type of 
epidemiological studies (Sternberg, 1998; Münnich & Lübke-Becker, 2004).  
 
The objective of Study III was to test the hypothesis that data on antimicrobial 
susceptibility in E. coli bacteria from urinary tract infections are representative 
also for E. coli isolates from pyometra. Changes in the proportions of resistance in 
isolates from both urinary tract samples and pyometra, were also evaluated during 
a ten-year period. Antimicrobial resistance among E. coli isolates from the uteri of 
bitches with pyometra was determined and compared with data from diagnostic 
submissions of urine samples of dogs. The urine sample isolates were grouped 
according to origin (animal hospitals or smaller clinics). From the authors of a 
previous pyometra study (Franklin, Horn af Rantzien & Mörner, 1996), raw data 
(minimum inhibitory concentrations, MICs) were obtained and one isolate per 
bitch was randomly selected to enable comparison. Raw data (MICs) from all 
antimicrobial susceptibility tests of E. coli isolated from urine samples of dogs at 
the Department of Bacteriology, SVA, during the years 1991-1993 and 2002-2003 
were retrieved from SVA.  
 
Study IV explored the hypothesis that bitches with pyometra have increased 
plasma levels of endotoxin in the circulation; in addition it investigated possible 
haematological or biochemical markers for endotoxin release. Plasma endotoxin 
concentrations were measured in ten bitches suffering from pyometra and with 
moderately to severely depressed general attitude (more prone to suffer from the 
effects of endotoxemia). To increase the possibilities of detecting fluctuating 
endotoxin levels, blood samples were taken on five occasions before, during and 
after surgery. In addition, the prostaglandin F2α metabolite 15-ketodihydro-PGF2α 
(PG-metabolite) was analysed.  
 
In Study V the hypotheses that PG-metabolite levels are elevated in bitches with 
pyometra and that they differ between bitches with pyometra and CEH were 
tested. PG-metabolite was evaluated in 58 bitches with pyometra, 11 bitches with 
CEH and 20 healthy controls. We had previously found that plasma levels of 
endotoxins were significantly increased in bitches with pyometra and that the 
endotoxin levels were correlated to the significantly elevated plasma PG-
metabolite concentrations (Study IV). These results indicated that analysis of PG-
metabolite could be a marker for endotoxemia and severity of the following 
systemic effects of the disease. To evaluate whether PG-metabolite analysis can 
act as a clinically useful marker for systemic inflammatory response syndrome 
(SIRS) in bitches with pyometra, a comparison of PG-metabolite levels in SIRS-
positive and SIRS-negative cases was performed. The chosen criteria for SIRS-
identification were the most sensitive alternatives applied for dogs (Hauptmann, 
Walshaw and Olivier, 1997). Possible correlations between PG-metabolite levels, 
clinical biochemical and hematological parameters, case history, clinical 
examinations and morbidity as measured by hospitalisation length, were also 
evaluated.   20
 
In addition to general notes on case history and results of the clinical 
examination the admitting clinician also determined the general attitude of the 
pyometra bitches to be moderately or severely affected, mucous membrane colour, 
dehydration status and whether the circulation was impaired (IV). In Study V the 
clinician filled out a form specifying rectal temperature, heart rate, respiratory rate, 
mucus membrane colour, capillary refill time, location for pain response at 
abdominal palpation, hydration status and general attitude on admission. After 
surgery the rectal temperature, heart rate and respiratory rate were recorded daily 
on a special form from which the length of hospitalisation was also determined 
(V). Information on treatment, complications to treatment and mortality (IV, V) 
were obtained from the medical records. 
 
 
Sampling 
Bacteriological examinations (II-IV) 
Samples for bacteriological examination of the uterus were obtained immediately 
after ovariohysterectomy as uterine biopsies (II, IV) or by inserting sterile fibre 
swabs (Culturette; Becton Dickinson AG) in the uterine lumen (III). For the 
uterine biopsies a 1x1 cm section of the uterine wall was aseptically removed, 
placed in a sterile vial and kept at 4 °C before culturing. In Study II the bacterial 
strains originated from uterine biopsies that were placed in thioglycolate medium 
prior to bacterial cultivation (Wadås et al., 1996). 
 
The urine samples used in Study II and IV were collected into a sterile syringe 
through cystocenthesis during surgery. In Study II the urine sample was 
immediately transported to the former Department of Clinical Microbiology, SLU, 
for bacterial isolation and identification. In Study IV the urine was poured onto 
agar dip-slides (Uricult®, Orion Diagnostica, Espoo, Finland) designed to isolate 
the most common human urinary tract pathogens, and cultured for 16-48 h at 37 
°C. If there was visible bacterial growth, the agar slides were transported to the 
Department of Bacteriology, SVA, Uppsala, Sweden, where isolation and 
identification was performed. In Study III, the collections of urinary tract E. coli 
strains originated from samples and dip-slide cultures submitted to the Department 
of Bacteriology, SVA, Uppsala, Sweden, from veterinary clinics and hospitals, for 
bacterial isolation and identification. These latter collections of urinary tract E. 
coli strains originated from urine of both male and female dogs (III). 
 
Blood analyses (IV-V) 
Blood samples for biochemical, hematological and PG-metabolite analysis were 
obtained by venopuncture of the distal cephalic vein immediately before surgery. 
EDTA, sodium-heparinised and non-additive vacutainer tubes (Becton-Dickinson, 
Stockholm, Sweden) were used for sample collection. Biochemical and 
hematological analyses were performed using routine methods, at the Department 
of Clinical Chemistry, SLU, Uppsala, Sweden. Sodium-heparinised plasma for 
PG-metabolite analysis (Study IV and V) and hormone (progesterone and   21 
oestradiol-17β) analysis (Study IV) was stored at -20°C until assayed at the 
Department of Obstetrics and Gynaecology and the Department of Clinical 
Chemistry, SLU, Uppsala, Sweden, respectively.  
 
Samples for plasma endotoxin analysis were obtained on five different 
occasions: (1) before induction of the general anaesthesia, (2) during skin incision, 
(3) immediately after uterus removal, (4) during skin suturing and (5) the day after 
surgery. Endotoxin-free vacutainer tubes containing sodium heparin (EndoTube 
ET®, Haemochrome AB, Göteborg, Sweden) were used to collect the blood 
samples. After sampling the tubes were immediately placed on ice and next 
centrifuged. The serum was then transferred to endotoxin-free glass tubes and 
stored at -20˚C, until transportation.  
 
 
Laboratory analyses  
Bacterial isolation, identification of E. coli and serotyping (ІІ-V) 
The bacterial isolations and identifications in Study II, III and IV were performed 
according to similar standard techniques at the former Department of Clinical 
Microbiology, SLU, Uppsala, and the Department of Bacteriology, SVA, Uppsala,  
Sweden (Holt et al., 1994; Barrow & Feltham, 1993). The uterine biopsies (II, IV) 
and fibre swab samples (III) were cultured on MacConkey agar plates (Oxoid, 
Basingstoke, UK) with subculture of morphologically typical E. coli isolates on 
horse blood agar (5% v/v) and bromchresol-purple lactose agar. All isolates of E. 
coli were identified by positive reactions for indole and p-nitrophenyl-β-D-
glucopyranodiduronic acid. Twenty-five strains of E. coli from 17 bitches with 
pyometra (collection A), in Study II, were serotyped by the Division of 
Diagnostics, Statens Serum Institut, Denmark. The production of α-hemolysin and 
presence of mannose-resistant or sensitive hemagglutination was also determined. 
 
 
Pulsed-field gel electrophoresis (ІІ) 
The DNA plugs were moulded according to the method described by Christensen 
and co-workers (1994) with some modifications. The freeze-stored E. coli cultures 
were thawed and subcultured twice before inoculating a single colony into 2 ml of 
Luria-Bertani (LB) broth. After 24 h incubation at 37 °C in an incubator shaker, 
growth was profound in all broth cultures. Viable count was performed on 
selected bacterial strains. The gel plugs were incubated at 56 °C for 20 h with 
proteinase K (Boehringer Mannheim, 1 mg/ml buffer). The restriction enzyme 
Xba 1 (MBI Fermentas, Hannover, USA) was used for the DNA digestion. The 
Lambda DNA-PFGE Marker (Pharmacia Biotech, Piscataway, USA) was added as 
a molecular size marker on double lanes of each gel as was also a typed ATCC-
strain of E. coli (ATCC No. 25922), in a minimum of two double gel lanes, to 
enable comparison among the different gels. The electrophoresis chamber (Gene 
Navigator System, Pharmacia, Biotech, Uppsala, Sweden) was used and the gel 
was run in a clamped homogenous electrical field (CHEF) system in six phases for 
a total of 22 h (5 s pulses for 3 h; 9 s pulses for 5 h; 12 s pulses for 5 h; 20 s pulses   22
for 4 h; 25 s pulses for 3 h; 30 s pulses for 2 h). After electrophoresis, the gel was 
stained in ethidium bromide solution (final concentration 0.4 µg ml
-1) for 30 min 
and photographed under 312 nm ultraviolet light. All strains were run in at least 
two lanes (double lanes) on each gel to avoid errors due to variability of the 
method. All DNA profiles on the gel photographs were examined by visual 
comparison and scanned by a flatbed scanner.  
 
Antimicrobial susceptibility tests (III) 
Susceptibility to antimicrobials was investigated using a commercially available 
microdilution system (VETMIC®, SVA). For the uterine isolates, microdilution 
panels with antimicrobials intended for monitoring of resistance were used 
(Ampicillin, Apramycin, Ceftiofur, Chloramphenicol, Enrofloxacin, Florfenicol, 
Gentamicin, Nalidic acid, Neomycin, Streptomycin, Sulphamethoxazole, 
Tetracycline, Trimethoprim). For the isolates from urine samples, break-point 
panels with a more limited range of antimicrobials, intended for clinical 
diagnostics, were used (Ampicillin, Chloramphenicol, Enrofloxacin, Gentamicin, 
Nitrofurantoin, Streptomycin, Sulphamethoxazole, Tetracycline, Trimethoprim, 
Trimethoprim-sulphamethoxazole). The determination of MICs was performed 
according to the standards of the National Committee of Clinical Laboratory 
Standards (NCCLS, 2000; NCCLS, 2002) using cation-adjusted Mueller-Hinton 
broth (Oxoid) with E. coli ATCC 25922 as a quality control. For all collections of 
isolates, microbiological criteria were used to define resistance (EUCAST, 2000; 
Kahlmeter  et al., 2003). An isolate was regarded as resistant to a specific 
antimicrobial when the MIC was higher than the highest MIC of the wild-type 
population (inherently susceptible population). 
 
Endotoxin, PG-metabolite and hormone analyses (IV-V) 
All freeze-stored samples for endotoxin determination were transported, cooled 
with freeze clamps, and arrived within four hours at the commercial laboratory 
Scan Dia Laboratory Services, Charlottenlund, Denmark, where the analyses were 
performed. The samples were analysed with a kinetic turbidimetric Limulus 
amoebocyte lysate (LAL) assay approved for endotoxin determinations by the 
Food and Drug Administration, USA (1987). At the Department of Clinical 
Sciences, SLU, Uppsala, Sweden, a radioimmunoassay (RIA) was used to analyse 
15-Ketodihydro-PGF2α (PG-metabolite) in duplicate (Granström & Kindahl, 
1982). Progesterone was analysed using an enhanced luminescence immunoassay 
(Immulite, Diagnostic Products Corporation, Los Angeles, CA, USA). Plasma 
oestradiol (E2-17β) concentration was determined using a modified double 
antibody RIA kit (Diagnostic Products Corporation, Los Angeles, CA, USA). 
  
 
Data analyses 
In Study I, dogs were considered pyometra cases if the owner had reimbursed 
claims for pyometra for veterinary care, and/or life irrespectively if they were 
reimbursed or not. Analyses for 1995 and 1996 were carried out separately. The 
crude and breed-specific median ages were calculated and the crude and breed-  23 
specific median ages at developing pyometra were determined. Twelve-month 
crude and age-specific risks (cumulative incidences, incidence proportions) were 
determined. For the 30 breeds with at least 800 bitches insured at the beginning of 
the years 1995 and 1996, breed-specific and breed-and age-specific 12-month risk 
were determined for each year. All the 12-month risks presented were adjusted. 
 
Because few Swedish bitches are neutered (Egenvall et al., 1999) and because 
neuter status was not included in the database, it was decided to adjust the number 
of dogs at risk in each age group, using the 12-month risk of pyometra in the 
previous age categories, as follows: The denominator in the first age category was 
un-adjusted. The denominator in the second age category was adjusted by the 12-
month risk of pyometra in the first age category (un-adjusted denominator 2nd age 
category)*(1-risk 1st age category) and the denominator in the third was adjusted by the 
12-month risk of pyometra in the first and second category (un-adjusted 
denominator 3rd age category)*(1-risk 1st age category)*(1-adjusted risk 2nd age category), and so 
on. Age- and breed-specific adjusted 12-month risks were used to estimate the 
cumulative crude and breed-specific risk of pyometra in each age category, using a 
combined risk formula: total risk in nth age category=1-(1-risk age category 
<1)*(1-risk age category 1<2 )*…*(1-risk age category n) (Kleinbaum, Kupper & 
Morgenstern, 1982).  
 
Multivariable analysis was conducted to simultaneously evaluate the effects of 
breed, location, urban versus rural environment and age upon the incidence of 
pyometra. In logistic regression analyses, breeds were represented by 29 dummy 
variables with mixed-breed dogs as the initial baseline. 
 
Since the use of chronological age to adjust for disease risk has its limitations 
(i.e. a 7-year-old poodle is not as physically “old” as a 7-year-old Bernese 
Mountain Dog), biological age for a given breed was defined as 0 to <10% 
mortality (age I), 10 to <20% mortality (age ІІ), 20 to <30% mortality (age III), 30 
to <40% mortality (age IV), and ≥40% mortality (age V), using data for all dogs 
from 1996 (male and female) (Egenvall, et al., 1998). Death estimates were 
calculated on all deaths regardless of whether they were caused by disease, trauma 
or euthanasia for non-medical reasons. 
 
In Study I, four sets of multivariable models were developed. In model I, all 
main effects except age were evaluated. Model II was the same as model I with all 
possible 2-way interactions evaluated. Model III was the same as model II, with 
the age variable included, but interactions with age were not tested. In the 4th 
model, interactions with age were tested. Models were reduced based on the 
change in deviance. The statistical software program SAS (SAS Institute, Cary, 
NC) was used to analyse the data, and the procedure GENMOD was used for 
logistic regression.  
 
In Study II, gel normalisation and cluster analysis was performed with the 
software GelCompar (Applied Maths, Kortijk, Belgium). In all gels, one double 
lane of the ATCC strain (ATCC No. 25922) was used as a standard for the 
normalisation of the gel. The other double lane of the ATCC strain was used as a   24
control for normalisation of the gel and for calculations of the reproducibility of 
the method. 
 
In Study III-V the software Statistica (Version 6.0, StatSoft Inc., Tulsa, USA) 
was used for performance of the analyses. The Pearson Chi-square statistic was 
used to assess observed differences in proportions of antimicrobial resistance 
between different subsets of isolates.  
  
In Study IV, a repeated measures ANOVA was used to test for differences in 
endotoxin means by patient group (control and pyometra) with sampling occasion 
of endotoxin level in plasma as repeated measures variable. A second repeated 
measures ANOVA was performed to test for differences in endotoxin means by 
general condition and sampling occasion within the pyometra patient group. 
Unpaired t-tests were used for groupwise comparisons of means of the two patient 
groups and endotoxin means of antibiotic-treated and untreated bitches. Pearson’s 
product moment correlation coefficient (rP) was calculated between endotoxin 
concentrations, PG-metabolite concentrations, other blood chemistry parameters 
and body temperature.  
 
A one-way ANOVA with a post-hoc Tukey test was used to test for differences 
in PG-metabolite levels by patient group (control, pyometra and CEH) in Study V. 
Fisher’s exact test, Spearman´s rank correlation coefficient (rS) and Pearson’s 
product moment correlation coefficient (rP) were used to test for associations 
between nominal- or ordinal-scale variables and interval-scale variables, 
respectively. Binary logistic regression analyses were used to evaluate blood 
parameters in relation to controls and bitches with pyometra or CEH. The 
regression models were tested for sensitivity and specificity. T-tests were used to 
test for differences in PG-metabolite levels between SIRS-positive and SIRS-
negative cases. This was tested for (1) a group consisting of both pyometras and 
CEHs, (2) the pyometra group, and (3) the CEH group.  
 
For further details, see paper I-V, respectively,  in the appendices. 
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Results and discussion 
The incidence of pyometra is breed- and age-dependent  
Breed dependency 
The results of the present thesis verify that pyometra is an important disease in 
intact bitches. Overall, almost 25% of the insured dog population had developed 
pyometra by 10 years of age. In the three breeds at highest risk of developing the 
disease in 1996 (rough-haired Collie, Rottweiler, Bernese Mountain Dog), 
approximately 50% of the bitches had experienced pyometra before reaching 10 
years of age (Table 1). The percentage of bitches that developed pyometra (judged 
by recorded reimbursement) before 10 years of age, in all 30 breeds included in 
the present study is shown in Table 1. 
 
Altogether, 1803 and 1754 bitches in 1995 and 1996 respectively, had claims for 
pyometra as recorded by reimbursed veterinary care claims, claims settled for life 
insurance, or both. The case fatality for pyometra was 4.3% in 1995 and 4.2% in 
1996, including both deaths and elective euthanasia. If it would have been possible 
to monitor the risk of pyometra also in older bitches, i.e. over 10 years of age, 
these figures would most likely be slightly higher. Not that age itself leads to an 
increased risk for fatal surgical complications in a healthy animal (Wheaton et al., 
1987), but the risk for other concurrent diseases increases with age thus increasing 
the risk of surgical complications or the owner’s choice of euthanasia. 
 
The crude 12-month risk of pyometra (the risk of a bitch developing pyometra 
during a specific year) for bitches less than 10 years of age, was 2%. The crude 
median age at development of pyometra in 1995 and 1996 was 6.5 and 6.9 years, 
respectively, but the true median age for pyometra in the general population 
including bitches of 10 years and older is probably higher (Niskanen & Thrusfield, 
1998). In Study III of the present thesis, the mean age for the sampled pyometra 
bitches was 8.6 years and in Study V it was 9.9 years, which is similar to previous 
studies (Dow, 1958; Hardy & Osborne, 1974). Interventions with for instance 
steroid hormone compounds may increase the risk of pyometra even at younger 
ages (Bowen et al., 1985; Niskanen & Thrusfield, 1998). In Sweden it is 
uncommon to administer steroid hormones such as oestrogen substances (the only 
drug registered for use against mismating in Sweden during 1995 and 1996) 
because of the risk of developing pyometra. 
 
Breeds with high risk of pyometra 
Breeds with high risk of the development of pyometra in the present study were 
Collie (rough-haired), Rottweiler, Cavalier King Charles Spaniel, Bernese 
Mountain Dog and Golden Retriever. The risks for the 30 breeds in the present 
study compared with risks for these breeds published in the studies by Krook, 
Larsson & Rooney (1960), Ewald (1961) and Niskanen & Thrusfield (1998) are 
shown in Table 1.  
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Table 1. Selected data of the 30 dog breeds investigated in the present study; showing total 
percentage of bitches up to 10 years of age reimbursed for pyometra, the risk of pyometra 
in the present study compared to the baseline, adjusted 12-month risk of developing 
pyometra in 1996 and references to the predisposition (A, B) and risk (C) in previous 
studies. Normal risk ↔; increased risk ↑; decreased risk ↓; NA= not analysed separately. A 
= Krook, Larsson & Rooney (1960); B = Ewald (1961); C = Niskanen & Thrusfield (1998).  
 
 
Breed  
 
 
Pyometra 
(%) before 
10 years 
of age 
 
Risk in 
the 
present 
study 
 
 
Risk  
(%) in 
year 
1996  
 
 
Risk or 
predisposition 
according  
to references 
Bernese Mountain Dog   54  ↑ 3.9  C:  ↔ 
Rottweiler 50  ↑ 4.4  AC:  ↑ 
Collie, rough-haired   46  ↑ 4.5  ABC:  ↑ 
Cavalier King Charles Spaniel   41  ↑ 3.8  C:  ↑ 
Golden Retriever   35  ↑ 3.3  C:  ↑ 
Shetland Sheepdog  30  ↔ 2.4   
German Pointer   29  ↔ 0.9   
Boxer   28  ↔ 2.7  A:  ↓ 
Jämthund 28  ↔ 2.4   
English Cocker Spaniel   27  ↑ 2.8   
West Highland White Terrier   26  ↔ 2.5  C:  ↔ 
English Springer Spaniel  25  ↔ 1.9  C:  ↔ 
German Shepherd Dog  25  ↓ 1.9   
Mixed breed   23  NA  NA  C: ↓ 
Labrador Retriever   22  ↔ 1.8  C:  ↔ 
Gråhund   17  ↔ 1.3   
Flat Coated Retriever  17  ↔ 1.4   
Drever   17  ↓ 1.6   
Swedish Hound   16  ↓ 1.2  A:  ↑ 
Papillion   16  ↔ 1.5   
Cairn Terrier   15  ↔ 1.6   
Finnish Hound   15  ↔ 1.4   
Yorkshire Terrier   15  ↔ 1.3   
Poodle, miniature/toy   14  ↔ 1.6  AB:  ↓ 
Dachshund, miniature   13  ↔ 0.3   
Dachshund (normal size and 
wirehaired)  
12  ↓ 1.1 AB  ↓, C: 
wirehaired ↓ 
Border Collie   12  ↔ 0.7   
Bichon Frisé   11  ↔ 1.2   
Bearded Collie   10  ↔ 0.9   
Beagle   10  ↔ 0.7     27 
Breeds with low risk of pyometra 
Breeds which had lower risk of developing pyometra in the present study were the 
Swedish Hound (models ІІІ and ІV, 1995), normal size Dachshund (all models, 
1995) and miniature Dachshund (all models) (Table 1). Lower risk was also found 
for the German Shepherd Dog and the Drever when adjusted for biological age 
(models ІІІ and ІV, both years). A reduced risk for mixed-breed dogs has been 
reported (Niskanen & Thrusfield), but mixed-breed dogs were used as a baseline 
for multivariable analysis in the present study and thus only separately analysed in 
the stratified analysis.  
 
Two of the cited studies are 20-40 years old, and one study was performed in the 
last decade (Ewald, 1961; Krook, Larsson & Rooney, 1960; Niskanen & 
Thrusfield, 1998). Ewald (1961) and Krook, Larsson & Rooney (1960) compared 
hospital cases and Swedish cases of pyometra from post mortem examination 
cases, respectively. These authors compared dogs with and without pyometra in 
their analyses. The external validity in studies based on post mortem examination 
cases might be low because such studies are prone to selection bias. Niskanen & 
Thrusfield (1998) used affected dogs and controls from primary care practices, a 
method that achieves high external validity. The base population was not 
considered in any of these studies. In the present study there was complete 
information on the base population but less complete information on the cases than 
in the other studies (i.e. it was only stated that the bitches were diagnosed with 
pyometra). 
 
Age dependency 
When biological age was added, most breed-specific risks decreased with the 
exception of the Golden Retriever, which increased. This breed clearly has an 
increased risk of developing pyometra and the effect is even more evident when 
adjusted for biological age since few Golden Retrievers die early. Two breeds 
entered the multivariable models when adjusting for biological age, the German 
Shepherd and the Drever, which then were implicated with lower risk of 
developing pyometra compared with the baseline. The low risk might reflect the 
fact that many dogs of these breeds die early (e.g. Drevers which are hunting dogs 
often die because of trauma). The results might have differed and these breeds 
been included in the baseline if the biological age variable had included only 
deaths due to disease (as opposed to deaths from trauma or disease).  
 
The interactions with biological age could be interpreted as that in some breeds 
(e.g. Rottweiler, rough-haired Collie, Golden Retriever, and Cavalier King Charles 
Spaniel in 1995), the risk of pyometra actually increases more and at an earlier age 
compared with other breeds. These breeds may carry a higher genetic 
predisposition for pyometra than other breeds. In general, breed differences may 
reflect true genetic differences or merely constitute a reflection of the different life 
spans in different breeds. If true genetic differences in predilection exist, the 
possibility of instituting breeding programmes to control the disease could be 
considered. Bernese Mountain Dogs were only at an increased risk in the models I 
and II, but dropped out when adjustments for biological age were made. The   28
reason that Bernese Mountain Dogs developed pyometra to the extent they did was 
probably because of the relatively high mortality before 10 years of age in that 
breed and not a true increased risk of pyometra in general. Some owners may want 
to neuter their bitches at an early age to prevent the development of pyometra. 
Given the different age patterns for risk, the maximum or optimal age for elective 
spaying differs among breeds. It is likely that the predisposition for pyometra is 
similar in other countries but that the common practice of neutering at an early age 
prevents recognition of the true disease frequency. 
 
 
Substantial genotypic variation in pyometra-inducing E. coli 
Bacterial epidemiology (II) 
The chromosomal restriction polymorphism which could be resolved by pulsed-
field gel electrophoresis (PFGE), was sufficient for a consistent differentiation of 
the various isolates, and strains from the 80 different bitches showed different 
DNA restriction fragment profiles (Fig. 2). The repeated examinations of the 
control strain showed a high reproducibility of the method between different gels. 
The variations of DNA-profiles of E. coli isolates from the uterus of different 
bitches with pyometra indicate that pyometra is caused by E. coli originating from 
the normal flora of the bitch and not by certain clones spread between animals.  
 
In the bitches where examination of several (8-16) colonies of E. coli from the 
uterus was performed, all isolates from the same bitch showed identical DNA 
profiles. This indicates that in cases of E. coli pyometra, only one bacterial clone 
establishes itself in the uterus, multiplies and acts as the main agent in the disease 
One genotype is therefore predominant in the uterus. This likely bacterial 
pathogenesis is in accordance with a study of human urinary tract infections by 
Arbeit and co-workers (1990) who showed by genotyping that the E. coli infection 
within a given patient is due to a single bacterial clone.  
 
The morphologically different mucoid and non-mucoid colonies found in some 
bitches were of the same genotype with identical DNA profiles in 16 of the 17 
bitches assayed. However, one strain from a pyometra bitch had one band located 
in different sites in the two forms of the strain. Since the PFGE was repeated and 
performed with double samples, it is not likely to be a difference caused by a 
methodical alteration.  
 
Isolates with identical PFGE patterns are considered to be clonal (Maslow, 
Slutsly & Arbeit, 1993; Tenover et al., 1995). Isolates with shifts of two or three 
bands are considered to be closely related although a point mutation, an insertion, 
a deletion or a chromosomal inversion has occurred. One single genetic event can 
give rise to up to three band differences, and therefore four or more bands should 
differ before an isolate is assigned to a different clone (Tenover et al., 1995). 
Others consider isolates as different strains when three or more bands are 
dissimilar (Maslow Slutsly & Arbeit, 1993). E coli stam 39 MH/H
E coli stam 39 H/MH
E coli stam 119 M/S
E coli stam 164 H
E coli stam 101 M/S
E coli stam 101 S/M
E coli stam 3 S
E coli  stam 112 S
E coli stam 109 H
E coli stam 124 S/H
E coli stam 132 S/M
E coli stam 25 S/M
E coli stam 104 MH/H
E coli stam 104 H/MH
E coli stam 53 MH/H
E coli stam 159 S/M
E coli stam 23 S/M
E coli stam 10 M/H
E coli stam 158 MH/H
E coli stam 158 H/MH
E coli stam 117 H
E coli stam 119 M/S
E coli stam 119 S/M
E coli stam 17 H
E coli stam 11 H
E coli stam 107 H/M
E coli stam 1 H/MH
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Fig. 2. Dendogram showing relations between DNA-profiles of E. coli isolates from pyometra 
cases. If more than one colony type was isolated from one bitch, the identification number of 
that bitch and the colony type characteristics (M = mucoid, S = smooth, H = smooth and 
hemolytic, MH = mucoid and hemolytic) for both isolates are listed. Isolates no. 31 and 34 are 
from the same uterus. 
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In our study, however, the different profiles of the DNA fragments between the 
mucoid and non-mucoid forms in one bitch never altered their type in more than 
one band, and can thus be considered to be the same clone. Contrary to 
expectations, in all but the case mentioned above, no evidence of the 
morphological differences was visible in the DNA-profile of the two colony types. 
This could be explained by the fact that a mutation has occurred, but lies within an 
area of the genome which is unaffected by the restriction enzyme Xba 1, and 
therefore was undetectable in this study. In this case the dissimilarity might appear 
if the procedure was repeated with other restriction enzymes. However, it is more 
likely that the genomes of the two forms are in fact identical and the only 
difference is whether their capability to produce hemolysin or mucopolysacharide 
is being expressed or not. Different morphological types of the same bacterial 
strain, mimicking mixed growth, have been shown in E. coli from urinary tract 
infections in man (Nichols, 1975). An advantage with PFGE is that genetic events 
which do not alter the main strain phenotype can be visible in the DNA fragment 
pattern if they change the mobility of a DNA-fragment. Point mutations occurring 
on an enzymatic cleavage site would also be detectable, however unlikely to occur 
in this case.  
 
Another observation was that E. coli isolates from the uterus and the urinary 
tract of the same animal were indistinguishable in the bitches with pyometra and 
simultaneous urinary tract infection (Study II). These results indicate that in cases 
of urinary tract infection and E. coli pyometra, the urinary tract and uterus are 
infected with the same bacterial strain (Sandholm, Vasenius & Kivistö, 1975; 
Järvinen, 1981; Wadås et al., 1996). Given that E. coli strains isolated from both 
pyometra and urinary tract infections have many potential virulence features in 
common (Sandholm, Vasenius & Kivistö, 1975; Senior, DeMan & Svanborg,   
1993; Wadås et al., 1996; Yuri et al., 1998; Chen et al., 2003), the infected urinary 
tract could supply pathogenic bacteria, invading the uterus when conditions are 
favourable.  
 
Prevalence and virulence attributes (II-IV) 
E. coli were isolated from 66% of the samples from pyometra bitches during the 
study period 2002-2003 in Study III. In Study IV the corresponding figure was 
90%. This dominance of E. coli is in accordance with previous studies on 
pyometra (Fransson et al., 1997; Dhaliwal, Wray & Noakes, 1998). Abundant 
growth of E. coli was isolated from 20% of the urine samples of the pyometra 
bitches in Study IV, but all other urine samples showed no bacterial growth. In 
Study II, collection A, 74% of the E. coli strains had smooth colony morphology 
whereas 26% were mucoid. On horse blood agar, 61% of the E. coli strains were 
hemolytic. Among the 96 isolates from ten bitches in collection C, mucoid, 
smooth, hemolytic and non-hemolytic colonies were present on the primary 
culture plates and chosen for analysis.  
 
Twenty-five strains of E. coli from 17 bitches with pyometra (collection A), in 
Study II, were serotyped in addition to genotyping (R. Hagman, unpublished data). 
The O-serotypes most commonly encountered were O4 (5 bitches), O6 (4 bitches)   31 
and O2 (3 bitches). O22, O76/O83, O18, O76, and O-autoagglutination were 
found in one bitch each. In the five bitches from which two morphologically 
different strains were isolated, both were of the same O-serotype. The finding that 
pyometra  E. coli commonly are clustered in serotypes O6, O4 and O2 is in 
accordance with the results of other studies (Grindlay, Renton & Ramsay, 1973; 
Sandholm, Vasenius & Kivistö, 1975; Dhaliwal, Wray & Noakes, 1998; Bigliardi 
et al., 2004). Capsule (K) antigens were found in 68% of the total number of 
strains, and in all bitches except 2 (88%). The presence of K-antigen is a well-
known virulence factor in urinary tract infections in man (Kalmansson et al., 
1975). However, in two of the five bitches from which two strains were isolated, 
capsular antigen was not present on both strains. Flagellar antigen was found in 
68% of the strains. Another common trait was the mannose resistant 
hemagglutination (MRHA), associated with the presence of P- and S-fimbriae, 
which was found in strains from 70% of the bitches. Type-1 fimbriae and the 
FimH adhesin are important for epithelial attachment and colonisation of 
uropathogenic E. coli in man, and as targets for protective vaccines (Langermann 
et al., 2000). Future studies determining E. coli virulence factors with the goal to 
explore possible prevention of E. coli attachment and infection by vaccination also 
in canine UTIs and pyometra, is an interesting progression. The results from the 
present serotyping indicate that the E. coli strains from the uterus of one bitch are 
of the same genotype but can be of different phenotypes and even serotypes 
depending on their gene expression. In serotype studies of pyometra, the selection 
of bacterial colonies from the initial culture plate does not affect the O-serotype 
grouping but certainly does influence the presence of other bacterial antigens.  
 
 
Antimicrobial resistance is unlikely to cause therapy failure 
Pyometra isolates 
The proportions of resistance to different antimicrobials in pyometra E. coli were 
low and of similar magnitude in both study periods (Table 2). Resistance to 
ampicillin was the most commonly observed trait among uterine isolates from 
2002-2003, and also in urine isolates from hospitals from both study periods. This 
is consistent with beta-lactam antibiotics, mostly aminopenicillins, being the most 
commonly used class of antimicrobials in dogs (Odensvik, Grave & Greko, 2001). 
When comparing pyometra isolates with isolates from urine samples submitted 
from animal hospitals in 2002-2003, significantly lower proportions of resistance 
to ampicillin, streptomycin and tetracycline were recorded (Fig. 3). However, no 
differences were observed when comparing pyometra isolates and urine isolates 
from animal clinics. General data on antimicrobial resistance in bacteria from 
urinary tract infections cannot be used as a guide for selection of antimicrobials 
for treatment of pyometra. 
 
In medical treatment of pyometra, antibacterial therapy is adjunctive to 
treatment with drugs such as prostaglandins or antiprogestins. In pyometra studies 
the duration of treatment varies from a few days (Gilbert, Nöthling & Oettle, 
1989) to four weeks or more (Meyers-Wallen, Goldschmidt & Flickinger, 1986).   32
Reported recurrence rates are generally high (Meyers-Wallen, Goldschmidt & 
Flickinger, 1986; Nelson, Feldman & Stabenfeldt, 1982; Gilbert, Nöthling & 
Oettle, 1989; Gobello et al., 2003). Meyers-Wallen, Goldschmidt & Flickinger 
(1986) suggested that recurrence may be a clinical manifestation of the same 
infection, rather than re-infection with a new bacterial strain. Based on the results 
of the present study, resistance to antimicrobials is not likely to be a major 
explanation for therapy failure. Other aspects, such as the pharmacodynamics of 
the chosen drugs, are more likely to influence the outcome in terms of antibacterial 
effect. Rekha & Krishnappa (2000) suggested that the bacterial growth inside the 
uterus is mainly in the form of biofilms. In such infections, both the slower growth 
rate of the infectious agent, and the diffusion barrier of the biofilm matrix itself 
must be considered when choosing the drug, the dosage and the duration of 
treatment (Gristina et al., 1987). In this study, susceptibility in isolates of E. coli 
from pyometra was mostly high, but multiresistance was also recorded, and 
therefore it is advisable to base selection of antimicrobials on culture and 
susceptibility tests. To further optimise the medical treatment of pyometra, more 
information on pharmacokinetic and pharmacodynamic relationships of 
antimicrobials in the diseased uterus is needed as a basis for selection of drug and 
dosage regimens. 
 
Table 2. Cut-off values for resistance  for 10 different antimicrobials and 
percentage resistance to these antimicrobials among Escherichia coli from 
pyometra and urine samples for two study periods. Pyo1 = pyometra samples 
1991-1993, Pyo2 = pyometra samples 2002-2003, Uri1 = urine samples 1991-
1993, Uri2 = urine samples 2002-2003. - = not tested. 
 
 
 
Antimicrobial 
 
Cut-off 
Values
a 
(mg l
-1) 
 
Pyo1 
n = 56 
(%) 
 
Uri1 
n = 96 
(%) 
 
Pyo2 
n = 80 
(%) 
 
Uri2 
n = 205 
(%) 
 
 
Ampicillin 
 
>8 
 
7 
 
22 
 
10 
 
15 
Chloramphenicol  >16  2 7 0 - 
Enrofloxacin  >0.25 2  11 4 8 
Gentamicin  >8 0 3 0 1 
Nitrofurantoin  >32 2 2 - 2 
Streptomycin >32  9  21  5
b 13 
Sulphametoxalate  >256 - - 8 - 
Tetracycline >8  9  23  4
b 10 
Trimethoprim  >8 - - 2 - 
Trimethoprim- 
          sulphamethoxazole 
 
>1 4  10 -  14
c
aValue above which the isolate was considered resistant, 
b79 isolates tested, 
c204 isolates 
tested. 
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Urinary tract isolates  
In 1991-1993, 96 isolates of E. coli had been tested for susceptibility at SVA. The 
corresponding figure for 2002-2003 was 205. Among E. coli from all urinary 
samples from 1991-1993, the proportions of resistance to ampicillin, streptomycin 
and tetracycline were above 20% (Table 2). The corresponding figures for 2002-
2003 were more than five percentage units lower, but when the data set was 
stratified by origin of the E. coli strains from animal hospitals or animal clinics 
there was no difference over the ten-year-period within the groups.  
 
In the present study, it is probable that an increased number of animals 
investigated at animal hospitals suffered from complicated urinary tract infections 
as compared with those attending animal clinics. The former group is more likely 
to have been exposed to previous antimicrobial treatment that may have selected 
for resistant bacterial strains, which could explain the higher proportions of 
resistance to ampicillin and streptomycin. This has been shown in humans where 
significantly higher resistance proportions are found among E. coli isolated from 
complicated urinary tract infections, as opposed to uncomplicated cases (Kerrn et 
al., 2002). 
 
Other antimicrobials commonly used to treat urinary tract infections are 
trimethoprim-sulphonamides and fluoroquinolones. The proportion of resistance 
to fluoroquinolones among isolates from urine samples was 7-12% (Table 2). The 
cut-off values chosen for this study are low compared to break-points recommend-
ed by, e.g., NCCLS (2002). Nonetheless, isolates with MIC >0.25 mg l
-1 have a 
decreased susceptibility compared with inherently susceptible strains, most 
probably because of at least one mutation in one of the genes encoding the target 
enzymes of this class of drugs (Webber & Piddock, 2001). Treatment of infections 
with such isolates with fluoroquinolones may well be successful, but there is a risk 
for further mutations to higher levels of resistance (Drlica, 2003). 
 
Multiresistance 
Four pyometra isolates from each study period were resistant to more than one 
antimicrobial. Seven of these isolates were resistant to both ampicillin and 
streptomycin, and six of these also to other drugs. In the urine samples, resistance 
to three antimicrobials or more (multiresistance) was observed in 15% and 9% of 
the isolates from 1991-1993 and 2002-2003, respectively. The most common 
combination was resistance to ampicillin and streptomycin, observed in 11% of 
the 301 isolates and of these, 78% were multiresistant.  
 
Multiresistance, with resistance to tetracycline, streptomycin and ampicillin 
being a common combination, has been reported in studies on resistance in E. coli 
isolated from faeces of healthy dogs and is mostly transfered by conjugation 
(Monaghan, Tierney & Colleran, 1981; Moss & Frost, 1984). The normal flora of 
the animals may thereby act as a reservoir from which resistance can be 
transferred to other, more virulent, bacteria of dogs. The risk of spread of 
resistance genes to bacteria colonising other animal species or people is difficult to assess, but needs to be considered (Sternberg, 1999; Münnich & Lübke-Becker, 
2004). 
 
 
Pyometra is associated with endotoxemia … 
Bitches suffering from pyometra had significantly higher plasma levels of 
endotoxins than the control bitches (Fig. 3). The mean endotoxin levels (of all 
sampling occasions) were 28 pg ml
-1 (range 14 to 52 pg ml
-1) in the control group 
and 49 pg ml
-1 (range 20 to 123 pg ml
-1) in the pyometra group. Thus, the ET 
concentrations in the present study are in the same order of magnitude as in the 
study by Okano, Tagawa & Takase (1998), but ten-fold lower than those reported 
by Wessels & Wells (1989). In samples taken immediately after removal of the 
uterus or at the end of the surgical procedure a significant difference in mean 
endotoxin levels was shown between the two patient groups. However, if sampling 
were to have taken place on only one occasion, no significant difference in mean 
endotoxin levels between the two patient groups would have been detected for the 
samplings before surgery, during skin incision or the day after surgery. The 
measurable differences in mean values for these sampling occasions were not 
statistically significant because of a large variation in the data. 
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Fig. 3. Plasma endotoxin levels in the control group and the pyometra bitches measured at 
five different sampling occasions; ET 1 = before general anaesthesia, ET 2 = during skin 
incision, ET 3 = after removal of the uterus/major part of the surgical procedure, ET 4 = 
during skin suturing, ET 5 = the day after surgery, ET X = mean endotoxin levels of all 
sampling occasions. Error bars represent 1 SE of the mean. The differences in endotoxin 
levels were significantly (P<0.05) higher in the pyometra bitches for sampling occasion 
ET 3, ET 4 and also for ET X.  
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The variations in ET levels between different studies of pyometra probably 
depend on study design, i.e. sampling procedures and case selection. Correct 
sampling technique and handling of the plasma samples is important to avoid 
contamination or binding of the ET to plasma proteins or sampling materials 
(Warren et al., 1985; Tobias, Soldau & Ulevitch, 1986). Differing results between 
studies (and sample occasions) may also depend on timing of the sampling 
considering the rapid clearance of ET from the circulation (Van Deventer et al., 
1987; Fox, Thomas & Broitman, 1990). Frequent sampling is therefore an 
advantage in the evaluation of endotoxemia compared with analysis at only one 
point in time.  
 
The biological effects of endotoxins in vivo not only depend on the amount of 
ET present in the blood but also on the susceptibility of the host (Galanos et al., 
1988). The sensitivity to ET varies between different animal species (McCuskey et 
al., 1984) and also between individuals within a species (Van Miert & Frens, 
1968). Higher ET susceptibility could explain why ET levels were not different in 
the bitches with severely depressed general condition when compared with those 
that were only moderately depressed. The rate of ET release also influences its 
effects. A certain tolerance to ET can be induced, where the individual response 
becomes less pronounced after repeated injections of the same amount of ET 
(Holst, Edqvist & Kindahl, 1993). As for prognostic value of endotoxin levels, all 
of the studied bitches survived in spite of six pyometra bitches having endotoxin 
concentrations >75 pg ml
-1 on at least one sampling occasion implicating a poor 
prognosis (death) according to the study by Okano, Tagawa & Takase (1998).  
 
In Study IV significant correlations were found between endotoxin 
concentrations (means of the five sampling occasions) and PG-metabolite, 
hemoglobin (Hb), packed red blood cell volume (PCV), lymphocytes, albumine 
and γ-globuline concentrations. The parameter that was correlated to ET levels as 
well as to most other features was PG-metabolite. This is not surprising as the 
potency of prostaglandins in inflammation and endotoxemia is well known 
(Bottoms, Johnson & Roesel, 1983). Since PG-metabolite is an accurate 
measurement of ET-induced prostaglandin synthesis and release in other species, 
the detection of PG-metabolite could be helpful in detecting endotoxemia also in 
dogs. The metabolite is more stable in plasma than ET, no prostaglandin-binding 
substances have been shown to be present in blood and the assay is more cost-
efficient than the present method for ET analysis. Unfortunately, a method is not 
yet available for routine use in veterinary clinics. The parameters Hb, PCV and γ-
globulins are not as specific for ET involvement as PG-metabolite since they may 
also be affected by dehydration. With the exception of bile acids and albumine, 
parameters indicating liver and kidney functions (BUN, creatinine) were not 
significantly correlated with the endotoxin or PG-metabolite concentrations.  
 
Symptoms previously linked with sublethal doses of endotoxin displayed by the 
pyometra bitches in Study IV and V respectively, were e.g. fever (60% and 50%), 
lethargy (90% and 85%), tachycardia (60% and 28%) and tachypnea (40% and 
25%) (Van Miert & Frens, 1968). Other endotoxin-linked symptoms such as   36
anorexia and vomiting were recorded in 50% and 70% of the pyometra bitches in 
Study IV and V (Van Miert & Frens, 1968).  
 
Mean values of selected biochemical and hematological blood parameters in 
Study V are presented in Table 3. The results from hematological and biochemical 
analyses of the pyometra groups in both Study IV and V generally confirm what 
previously has been shown in bitches with pyometra (Børresen, 1980; Fransson, 
2003). The significantly increased α2-,  β1- and γ-globulin fractions of serum 
proteins in the pyometra bitches compared with the controls (Study IV) are likely 
to reflect an increased synthesis of acute phase proteins and antibodies in response 
to the bacterial infection. Toxic effects on granulocytes and erythrocytes in seven 
(Study IV) and two (Study V) of the pyometra cases, respectively, confirm the 
influence of toxins. In 20% of the pyometra bitches in Study IV, bile acid 
concentrations were elevated, which could result from the intrahepatic cholestasis 
previously associated with pyometra in bitches (Børresen & Skrede, 1980). In pigs 
elevated bile acids (and PG-metabolite levels) are seen as a result of 
experimentally injected ET, explained by cell damage of the hepatocytes, 
prostaglandin-induced impaired liver function and metabolism and slow bile flow 
(Holst, Edqvist & Kindahl., 1993). Increased blood level of cholesterol, as 
confirmed in the pyometra bitches in both Study IV and V, is also a feature of 
intrahepatic cholestasis. Hypocalcemia, shown to be a result of endotoxin 
injections in pigs (Holst, Edqvist & Kindahl, 1993), goats (Fredriksson, Kindahl & 
Edqvist, 1984) and cattle (Aiumlamai & Kindahl, 1990) was, however, not 
associated with pyometra. Only mild hypocalcemia was detected in two of the 
pyometra bitches in Study V.  
 
Based on the above mentioned findings, it may be possible that treatments 
tempering the release or effects of endotoxin (Fletcher & Ramwell, 1977; 
Odensvik & Magnusson, 1996), can be beneficial for bitches with pyometra.  
 
 
… and with increased levels of prostaglandin F2α
Of the 69 bitches included in Study V, 58 were diagnosed with pyometra and 11 
with CEH. The results showed that the levels of PG-metabolite were significantly 
increased in bitches with pyometra compared with bitches with CEH in Study IV 
(P=0.01) and the controls in Study IV and V (P<0.05 and P≤0.001 respectively). 
The number of bitches in the different patient groups and controls in Study V, 
divided into five different categories of PG-metabolite levels, are illustrated in Fig. 
4. Mean PG-metabolite levels, ranges and standard deviations for the different 
groups are displayed in Table 3. In Study IV the mean level of PG-metabolite in 
the bitches with pyometra was 9830 pmol l
-1. 
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Fig. 4. Percentage of the controls, cystic endometrial hyperplasia (CEH) and pyometra 
bitches as divided into five groups according to their prostaglandin F2α metabolite (PG-
metabolite) plasma levels. 
≥10000 
 
The increased concentrations of PG-metabolite in bitches with pyometra are 
most likely derived from endometrial synthesis of prostaglandins initiated by the 
uterine bacterial infection and subsequent endotoxin release, as is observed in 
many animal species (Heap & Poyser, 1975; Hughes et al., 1979; Aiumlamai & 
Kindahl, 1990; Vandeplassche, Coryn & De Schepper, 1991; Mateus et al., 2003). 
The levels of PG-metabolite were, however, not significantly higher in bitches 
with CEH compared with the controls. This can be explained by the lack of 
bacterial infection and endotoxemia in cases with CEH. Any inflammation present 
in the CEH group, as indicated by higher mean levels of PG-metabolite compared 
with the control group, was not significant (Table 3). 
 
 
  37   38
Table 3. Mean values and standard deviation (SD) for selected hematological and blood 
chemistry parameters in bitches with pyometra or CEH and healthy controls in Study V. 
Temperature=body temperature; PG-metabolite=prostaglandin F2α metabolite; EVF=red 
blood cell volume fraction; WBC=white blood cell count; PBN=percentage band 
neutrophils; BN=band neutrophils; Neutrophils=segmented neutrophils; ALAT=alanine 
amino transferase; AP=alkaline phosphatase; BUN=blood urea nitrogen. 
 
  Control    CEH    Pyometra 
  Mean ± SD 
 
n    Mean ± SD 
 
n    Mean ± SD  n 
Temperature 
   (˚C) 
38.7 ± 0.4  20    39.1 ± 0.7   8    39.1 ± 0.6  56 
PG-metabolite 
   (pmol l
-1) 
78 ± 208 
 
20    377 ± 956  11    6278 ± 5757  58 
Hemoglobin 
   (g l
-1) 
173 ± 17.3  20    138 ± 19.4  11    136 ± 24.4  57 
EVF 
   (%) 
0.50 ± 0.05  20    0.39 ± 0.05  11    0.38 ± 0.07  57 
WBC  
   (10
9 l
-1) 
8.8 ± 2.6 
 
20    10.6 ± 6.4  11    22.8 ± 11.4  56 
BN 
   (10
9 l
-1) 
0.01 ± 0.02  20    0.55 ± 1.25  11    2.86 ± 2.96  56 
PBN 
   (%) 
0.05 ± 0.22 
 
20    3.00 ± 6.19 
 
11    11.9 ± 9.97 
 
56 
Neutrophils 
   (10
9 l
-1) 
5.5 ± 1.7 
 
20    7.8 ± 5.0  11    15.3 ± 8.1  56 
Eosinophils 
   (10
9 l
-1) 
0.7 ± 0.6 
 
20    0.3 ± 0.3  11    0.3 ± 0.6 
 
56 
Lymphocytes  
   (10
9 l
-1) 
2.1 ± 0.9 
 
20    1.0 ± 0.5  11    1.5 ± 0.9 
 
56 
Monocytes 
   (10
9 l
-1) 
0.4 ± 0.2 
 
20    0.9 ± 0.5  11    2.8±2.3 
 
56 
Platelet count 
   (10
9 l
-1) 
312 ± 102  20    250 ± 104  10    233 ± 118 
 
55 
Creatinine 
   (µmol l
-1) 
86 ± 22 
 
20   77  ±29 
 
 9    81 ± 42 
 
53 
ALAT  
   (µkat l
-1) 
0.6 ± 0.3 
 
19    0.6 ± 0.4  10    0.6 ± 0.8 
 
57 
AP  
   (µkat l
-1) 
1.7 ± 0.9 
 
20    2.6 ± 2.3   9    6.0 ± 6.0 
 
57 
BUN 
 (mmol l
-1) 
6.6 ± 2.9 
 
20    4.6 ± 1.7   9    5.1 ± 4.0 
 
48 
Protein  
   (g l
-1) 
79 ± 7 
 
20    77 ± 6   9    80 ± 13 
 
49 
Albumin  
   (g l
-1) 
34 ± 4 
 
20    31 ± 3   9    27 ± 5 
 
49 
Cholesterol  
   (mmol l
-1) 
7.4 ± 2.0 
 
20    7.3 ± 2.6   9    9.8 ± 2.5 
 
48 
Calcium  
   (mmol l
-1) 
2.7 ± 0.3 
 
20    2.7 ± 0.2   9    2.6 ± 0.3 
 
48 
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PG-metabolite was correlated to a large number of measured parameters in both 
Study IV and V, including Hb, WBC, BN, segmented neutrophils, monocytes and 
albumin. In addition, correlations were found between PG-metabolite and bile 
acids, albumine/globuline quota, γ-globulines and β-1 globuline fraction of serum 
protein electrophoresis in Study IV. In Study V, PG-metabolite levels were 
significantly correlated to EVF, PBN, lymphocytes, MCV, creatinine, ALAT, 
glucose, and cholesterol. PG-metabolite levels were also significantly correlated to 
clinical findings including duration of illness prior to admission to the clinic 
(according to information from the owner), length of the hospitalisation, the 
general clinical condition of the bitch, rectal temperature, heart rate and degree of 
dehydration at the time of admission. 
 
As for prognostic value, the PG-metabolite concentrations were correlated to 
morbidity as measured by length of the hospitalisation and the general state of 
health of the bitch at admission (Study V). Bitches operated for pyometra are 
generally dismissed 1-2 days after surgery. Additional complications with severely 
depressed general condition will result in longer hospitalisation, a factor used for 
these estimations also in studies in man (Afessa et al., 2001). The preoperative 
measurement of PG-metabolite can thus help the clinician in roughly determining 
the systemic severity of the pyometra. 
 
To be able to evaluate the possible value of PG-metabolite in the prediction of 
survival or death, more patients are needed since only two bitches died of causes 
related to pyometra in Studies IV and V. Two other bitches died, 2 and 14 days 
after surgery respectively, but it is uncertain whether the deaths were 
consequences of the pyometra since no autopsies were performed. The bitch with 
the highest observed level of PG-metabolite, 33,500 pmol l
-1, died the day after 
surgery as a consequence of myocarditis and other sequela of disseminated 
bacterial infection. The other confirmed death was a bitch with a thin-walled 
uterus which ruptured during the operation. That bitch died one hour after the 
surgery was completed but had low (400 pmol l
-1) levels of PG-metabolite before 
surgery. This was perhaps an example of severely damaged or atrophic 
endometrium which reduces the endogenous production of prostaglandins, as has 
been described in the mare (Hughes et al., 1979).  
 
The levels of PG-metabolite were correlated to rectal temperature, heart rate, 
degree of dehydration, WBC and PBN. These are four out of five of the clinical 
criteria used to determine whether the systemic inflammatory response syndrome 
(SIRS) is present. The presence of SIRS has clinical importance since it has been 
linked with higher mortality (Brady & Otto, 2001; Okano et al., 2002). When PG-
metabolite levels in bitches with and without SIRS were compared, the differences 
were significant for the group consisting of both pyometras and CEH cases, just 
significant for the pyometra group but not significant for the CEH group (Fig. 5). 
PG-metabolite analysis could therefore be valuable in the detection of systemic 
inflammation if a rapid test for veterinary clinics becomes available in the future.  
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Fig. 5. Prostaglandin F2α metabolite (PG-metabolite) concentrations in controls and 
bitches with cystic endometrial hyperplasia (CEH) or pyometra, with and without a 
systemic inflammatory response (SIRS). Bars indicate 1 standard error of the mean. 
 
PG-metabolite distinguishes pyometra from CEH 
The separation of bitches with pyometra from bitches with CEH can be clinically 
difficult. Fluid in the uterine lumen may be detected by diagnostic imaging in both 
conditions, and the clinical presentation, history and laboratory parameters are 
very similar (De Bosschere et al., 2001; Fransson et al., 2004). Bitches with 
pyometra should be regarded as emergencies since there is a risk of uterine 
rupture, endotoxic chock and rapid deterioration of the general status. In contrast, 
in bitches with CEH surgery can, if necessary, be postponed until optimal surgical 
conditions are available without further negative consequences for the bitch. 
Clinically it would therefore be helpful to accurately predict the diagnosis before 
surgery to optimise treatments. 
 
Clinical examinations useful to differentiate between pyometra and CEH are the 
general attitude of the bitch at the time of admission, lethargy and gastrointestinal 
signs as confirmed in the present study (Table 4). These symptoms might reflect 
the presence of endotoxemia in pyometra as opposed to in CEH. The 
hematological and blood biochemical parameters that displayed significant 
differences between bitches with pyometra and CEH are shown in Table 5.  
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Table 4. The presence of selected abnormal case history and physical examination findings 
in bitches with pyometra or cystic endometrial hyperplasia (CEH) and significant 
differences between the two patient groups.  
 
History / clinical finding  CEH  
(n=11) 
Pyometra  
(n=58) 
 
P-value 
(Fisher’s 
exact test) 
Gastro-intestinal signs  10% (10)  70% (56)  <0.001 
Lethargy  10% (10)  64% (56)   0.004 
Attitude ≥ moderately 
depressed at admission   40% (10)  85% (55)   0.005 
 
 
Table 5. Mean and standard deviations for selected hematological and blood biochemical 
parameters that were significantly different in bitches with pyometra compared with cystic 
endometrial hyperplasia. PG-metabolite = prostaglandin metabolite 15-keto-13,14-dihydro-
PGF2α; WBC = White blood cell count; PBN = percentage band neutrophils. Two-sample 
T-tests were used for the calculations of P-values. 
 
  
 
 
 
Pyometra  
Mean (±SD) 
 
N 
CEH  
Mean (±SD) 
 
N 
 
P-value 
 
PG-
metabolite 
   (pmol l
-1) 
 
6278 (±5757)  58  377 (±956)  11  0.001 
WBC 
   (10
9 l
-1) 
 
22.8 (±11.4)  56  10.6 (±6.4)  11  0.001 
Band 
neutrophils  
   (10
9 l
-1) 
 
2.86 (±2.96)  56  0.55 (±1.25)  11  0.015 
PBN 
   (%) 
 
11.9 (±9.97)  56  3.00 (±6.19)  11  0.001 
Segmented 
neutrophils  
   (10
9 l
-1) 
 
15.3 (± 8.1)  56  7.8 (± 5.0)  11  0.006 
Monocytes 
   (10
9 l
-1) 
 
2.8 (±2.3)  56  0.9 (± 0.5)  11  0.010 
Cholesterol 
   (mmol l
-1) 
 
9.8 (± 2.5)  48  7.3 (± 2.6)   9  0.009 
Albumin  
   (g l
-1) 
 
27 (± 5)  49  31 (± 3)   9  0.026 PG-metabolite was the single parameter with highest sensitivity (96.6%) and 
specificity (90.9%) for the differentiation of pyometra versus CEH. This 
sensitivity is higher than what has been reported for any single parameter 
previously in this differentiation (Fransson et al., 2004). Routine blood parameters 
such as WBC, BN, monocytes, albumin, and ALP have low diagnostic value 
because of low specificity (≤18.1%). Combining PG-metabolite with each of these 
parameters led to decreased specificity as compared with PG-metabolite alone. 
The sensitivity also slightly decreased, except for the combination of PG-
metabolite and WBC, which yielded a sensitivity of 98.2% (specificity 81.8%). In 
clinical work it is preferred to have a highly sensitive test since the surgery on a 
“false positive pyometra” (CEH) patient is less risky compared with a pyometra 
falsely diagnosed as CEH and perhaps not monitored and treated as an emergency. 
An absolute identification of pyometra versus CEH was obtained when combining 
the analysis of PG-metabolite with PBN, which yielded a sensitivity of 100.0% 
and a specificity of 81.8%. The equation used for calculation of the estimated 
probability the diagnosis pyometra versus CEH for PG-metabolite in combination 
with PBN (as shown in Fig. 6) was as follows:  
 
Estimated probability of pyometra = exp (-0.9684 + (0.001082)*PG-metabolite+ 
(0.077413)*PBN) / (1+exp(-0.9684+(0.001082)*PG-metabolite + 
(0.077413)*PBN)). P≤0.0001. 
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Fig. 6. Contour plot of estimated 80%, 90%, 95% and 99% probability of pyometra 
versus cystic endometrial hyperplasia (CEH) in a bitch based on percentage band 
neutrophils (PBN) and plasma prostaglandin F2α metabolite (PG-metabolite) 
concentrations. Bisection of the values for PBN and PG-metabolite to the right of each 
respective graph indicates 80%, 90%, 95% or 99% probability of the diagnosis 
pyometra.   43 
Furthermore, if PG-metabolite was used alone and if the PG-metabolite level in 
a bitch is 4734 pmol l
-1, there is a 99% probability of the diagnosis pyometra 
versus CEH. PG-metabolite levels of 3232 pmol l
-1, 2552 pmol l
-1 and of 1815 
pmol l
-1 indicate a 95%, 90% or 80% probability of pyometra, respectively. The 
formula obtained in this case was:  
 
Estimated probability of pyometra = exp(-0.60784+0.001099*PG-metabolite) / 
(1+ exp(-0.60784+0.001099*PG-metabolite)). P<0.0001. 
 
The analysis of PG-metabolite concentrations therefore has high diagnostic value. 
At high PG-metabolite levels (above about 3000 pmol l
-1), PG-metabolite alone is 
enough for differentiation of pyometra from CEH, but at lower PG-metabolite 
levels (about 2000 pmol l
-1) the combination of PG-metabolite with PBN, WBC or 
BN (if sufficiently high) will increase the probability of detection of pyometra 
(formulas regarding WBC and BN not shown).  
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Conclusions 
The results presented in this thesis yield the following conclusions: 
 
• There are clear age- and breed-related differences in the incidence of pyometra 
in bitches in Sweden, which should be taken into account when studying the 
disease. It is probable that some breeds carry a higher genetic predisposition for 
pyometra than other breeds. Given the different age patterns for risk, the 
maximum or optimal age for elective spaying to prevent pyometra differs among 
breeds. 
 
•   Uterine E. coli isolates from different bitches with pyometra are genetically 
different. Pyometra is thus not caused by one or a few bacterial clones spread 
between animals but more likely by bacteria with origin in the normal flora of 
each bitch.  Genetically similar E. coli strains from one pyometra uterus can 
exhibit different colony morphology. In cases of E. coli pyometra with a 
concurrent subclinical urinary tract infection, the urinary tract and the uterus are 
likely to be infected with the same bacterial strain.  
 
• Antimicrobial resistance is not a likely cause for recurrence after medical 
treatment of E. coli pyometra in Sweden. Data on antimicrobial susceptibility of E. 
coli from urinary tract infections is not suitable as basis for antimicrobial drug 
selection in treatment of E. coli pyometra. 
 
•  Bitches with pyometra have increased plasma levels of endotoxin.  
 
• Plasma concentrations of the PG-metabolite provide a good indicator of 
endotoxin release in bitches with pyometra. Other hematological and blood 
biochemical parameters were not as useful as PG-metabolite for that purpose. 
 
• PG-metabolite analysis is useful in the differentiation between pyometra and 
CEH.  
 
•  PG-metabolite analysis is also valuable for the prediction of increased morbidity 
in pyometra, as measured by hospitalisation length or presence of the systemic 
inflammatory response syndrome (SIRS).    45 
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Populärvetenskaplig sammanfattning 
Pyometra, eller varbildande livmoderinflammation, är en vanlig sjukdom hos 
hundar som ger upphov till symtom från reproduktionsorganen och många andra 
av kroppens organsystem. Sjukdomen är dödlig om den inte behandlas, och vissa 
tikar är så allvarligt allmänpåverkade att de inte överlever, trots behandling. Syftet 
med denna avhandling var att undersöka epidemiologiska, bakteriella och 
inflammatoriska aspekter av sjukdomsutvecklingen vid pyometra. Ökad kunskap 
inom dessa områden kan komma att leda till optimerade behandlingsrutiner och 
ökade möjligheter att på sikt minska eller förhindra uppkomsten av sjukdomen. 
  
Uppgifter från hundar försäkrade i försäkringsbolaget Agria användes till att 
undersöka skillnader i förekomsten av pyometra med avseende på ålder och ras. 
Av de tikar som ingick i studien drabbades i genomsnitt 23-24 % av pyometra före 
10 års ålder. Andelen varierade mellan 10 % och 54 % beroende på ras. Det finns 
således viktiga ras- och åldersrelaterade skillnader i förekomsten av pyometra. 
Raser med en hög risk att utveckla pyometra är långhårig collie, rottweiler, 
cavalier king charles spaniel, golden retriever, berner sennenhund och engelsk 
cocker spaniel. Raser med låg risk att utveckla sjukdomen är drever, schäfer, tax 
(miniatyr och normalstor) och hamiltonstövare. 
 
För att utvärdera om de bakteriekloner som orsakar sjukdomen är nära 
besläktade utfördes en genotypisk undersökning av Escherichia coli (E. coli), den 
bakterie som vanligen isoleras vid pyometra. Resultaten visar att infektionen inte 
orsakas av en eller ett fåtal bakteriekloner. Bakteriestammarna uppvisar en stor 
variation vilket tyder på att ursprunget är kopplat till tikens normala bakterieflora. 
Alla bakterieisolat från en och samma livmoder är dock av samma genotyp. I fall 
av pyometra och samtidig subklinisk urinvägsinfektion, är troligen både livmoder 
och urinvägar infekterade med samma bakteriestam. 
  
Vid antibiotikabehandling av tikar med pyometra grundar sig valet av preparat 
oftast på studier gjorda i andra länder och främst gällande E. coli från 
urinvägsinfektioner. I denna studie undersöktes den antimikrobiella känsligheten 
hos  E. coli för de i hundpraktik mest använda antibiotikapreparaten. 
Bakteriestammarna var isolat från både tikar med pyometra och hundar med 
urinvägsinfektioner. Dessutom jämfördes dessa data med motsvarande resultat 
från en liknande samling med 10 år äldre data för att avgöra om någon skillnad i 
resistensutveckling kunde påvisas. I regel var resistensen för antimikrobiella 
preparat låg, och inga större förändringar påvisades under en tioårsperiod. Hos 
bakterieisolat från pyometra var känsligheten högre för ampicillin, streptomycin 
och tetracykliner jämfört med urinvägsisolat inskickade från djur som behandlats 
på djursjukhus. Det var dock ingen skillnad när urinvägsisolat från hundar som 
behandlats på mindre djurkliniker jämfördes med pyometraisolat. Generellt sett 
bör således inte resultat från undersökningar av E. coli från urinvägsinfektioner 
användas som bas för val av antibiotika vid behandling av pyometra.  
   55 
Förekomst och inverkan av endotoxiner från Gram-negativa bakterier som E. 
coli vid sjukdomsutvecklingen av pyometra hos hundar undersöktes i en klinisk 
studie. Hos andra djurslag har koncentrationer av prostaglandin F2α (som mäts 
genom sin metabolit 15-keto-13,14-dihydro-PGF2α) (PG-metabolit) visat sig vara 
en känslig indikator för endotoxin i blodet och frisätts dessutom vid 
inflammationer i livmodern. Därför utvärderades om koncentrationen endotoxin i 
blodet var korrelerad med PG-metabolitnivån även hos tikar med pyometra. Hur 
halten av endotoxiner relaterar till andra blodbilds- och biokemiska analyser 
undersöktes också. Resultaten bekräftar att tikar med pyometra hade förhöjda 
nivåer av endotoxin och PG-metabolit i blodet. PG-metabolit kan vara en indikator 
för graden av endotoxinpåverkan hos hundar med pyometra eftersom dess nivåer 
var signifikant korrelerade med halten av endotoxin och analysen är jämförelsevis 
pålitlig och kostnadseffektiv. 
  
Koncentrationer av PG-metabolit i blodet hos tikar med pyometra eller cystisk 
endometrie hyperplasi (CEH)/mucometra undersöktes för att avgöra om nivåerna 
kan skilja de båda sjukdomstillstånden åt. Vidare utfördes en rad biokemiska och 
blodbildsanalyser samt bedömningar om kliniskt status hos patienterna. Tikar med 
pyometra hade signifikant högre nivåer av PG-metabolit i blodet jämfört med tikar 
med CEH och friska kontrollhundar. Som ensam analys hade PG-metabolit en god 
förmåga (sensitivitet 96.6% och specificitet 90.6%), att identifiera om en tik led av 
pyometra eller CEH. Om både analys av procent stavkärniga neutrofila 
granulocyter och PG-metabolitnivåer användes kunde samtliga tikar med 
pyometra skiljas från de med CEH (sensitivitet 100 % och specificitet 81,8 %). 
Analys av PG-metabolit kan dessutom användas som ett mått på hur allvarligt 
sjukdomstillståndet är hos en tik med pyometra. PG-metabolitnivåerna var 
korrelerade både till antal dagar patienten fick stanna på djursjukhuset efter 
operation och till förekomsten av ett systemisk inflammationssvar (vilket vid 
andra sjukdomar har kopplats till högre dödlighet).  
 
Sammanfattningsvis bidrar resultaten av denna avhandling med data om ras- och 
åldersrelaterade skillnader vid förekomsten av pyometra, vilket kan vara till stor 
nytta för framtida forskning och tänkbara avelsprogram. Dessutom framkommer 
flera viktiga bakteriologiska och patofysiologiska fakta om sjukdomsutvecklingen. 
Dessa fakta kan i sin tur leda till en förbättrad diagnostik samt effektivare 
behandlingsstrategier för tikar med pyometra som därmed minskar lidandet och 
ökar överlevnadsfrekvensen.  
  